Inducible Co-stimulator Gene With Systemic Lupus Erythematosus

NCT07675837 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2026-06-30

No results posted yet for this study

Summary

The aim of this study is to investigate the association between ICOS gene polymorphism and susceptibility to systemic lupus erythematosus (SLE), as well as its impact on disease severity.

Conditions

  • Systemic Lupus Erthematosus

Sponsors & Collaborators

  • South Valley University

    lead OTHER

Principal Investigators

  • Eisa Mohammed Hegazy, Professor · Dermatology, Venereology & Andrology Department ,Faculty of Medicine ,South Valley University.

  • Mohammed Hosny Hassan, Professor · Biochemistry , Qena faculty of medicine ,south valley university.

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-06-30
Primary Completion
2027-06-30
Completion
2027-07-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07675837 on ClinicalTrials.gov